Copeland Capital Management LLC Has $286,000 Stake in UnitedHealth Group Incorporated $UNH

Copeland Capital Management LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 98.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 829 shares of the healthcare conglomerate’s stock after selling 40,266 shares during the period. Copeland Capital Management LLC’s holdings in UnitedHealth Group were worth $286,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC increased its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its holdings in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. Unisphere Establishment boosted its holdings in shares of UnitedHealth Group by 12.5% during the first quarter. Unisphere Establishment now owns 450,000 shares of the healthcare conglomerate’s stock worth $235,688,000 after acquiring an additional 50,000 shares during the period. Rench Wealth Management Inc. increased its stake in shares of UnitedHealth Group by 2.9% during the first quarter. Rench Wealth Management Inc. now owns 11,286 shares of the healthcare conglomerate’s stock worth $5,911,000 after purchasing an additional 314 shares during the period. Finally, Empyrean Capital Partners LP bought a new stake in UnitedHealth Group in the 1st quarter valued at $62,850,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.0%

Shares of UNH opened at $332.13 on Wednesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The firm has a market cap of $300.86 billion, a price-to-earnings ratio of 17.33, a PEG ratio of 2.14 and a beta of 0.43. The business’s fifty day moving average is $332.33 and its 200-day moving average is $319.37.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $7.15 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. Barclays boosted their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Bank of America increased their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. JPMorgan Chase & Co. lifted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, KeyCorp increased their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $385.54.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.